- Exchanges
- BSE, NSE
- Industry
- Pharmaceuticals
- Issue
- Book building
Anlon Healthcare IPO
₹91.73
+0.80% on listing
Listing-day close · NSE · 3 Sep 2025 · issue price ₹91
Anlon Healthcare’s ₹121 crore IPO was priced at ₹91 a share. It listed on the NSE on 3 Sep 2025 and closed its first day at ₹91.73, up 0.80% on the issue price.
Timeline
- Opens
- Closes
- Allotment
- Refunds
- Shares in demat
- Listing
Issue details
- Issue size
- ₹121 Cr
- Fresh issue
- ₹121 Cr
- Offer for sale
- —
- Lot size
- 164 shares
- Minimum investment
- ₹14,924
- Face value
- ₹10
- Registrar
- Kfin Technologies
Subscription
| Category | Shares offered | Times subscribed |
|---|---|---|
| Total | — | 6.95× |
Overall, from the basis of allotment.
Financials and valuation
- Market cap (post-issue)
- ₹484 Cr
- P/E (post-issue)
- 23.6
- EPS (post-issue)
- ₹3.86
- Price to book
- 4.5
- ROE
- 40.45%
- ROCE
- 21.93%
- Debt to equity
- 0.73
- EBITDA margin
- 26.88%
- PAT margin
- 17.06%
- Promoter holding
- 70.26% → 52.68%
Financials as of 31 Mar 2025, from the offer documents.
Listing
- Listing date
- 3 Sep 2025
- Issue price
- ₹91
- Open
- ₹92.00
- High
- ₹92.50
- Low
- ₹90.78
- Close
- ₹91.73
Listing day on the NSE. The close was +0.80% on the issue price.
ANLON HEALTHCARE share price todayFAQs
When did the Anlon Healthcare IPO open and close?
It opened on 26 Aug 2025 and closed on 29 Aug 2025.
What was the Anlon Healthcare IPO price?
The price band was ₹86–91 a share. The final issue price was ₹91.
What is the lot size and minimum investment?
One lot is 164 shares, ₹14,924 at ₹91 a share. Retail investors apply in whole lots.
How much did Anlon Healthcare raise?
₹121 crore: ₹121 crore of new shares.
How many times was the Anlon Healthcare IPO subscribed?
6.95 times overall.
How did Anlon Healthcare list?
It listed on the NSE on 3 Sep 2025 at ₹92.00 and closed the day at ₹91.73, up 0.80% on the ₹91 issue price.
Who is the registrar of the Anlon Healthcare IPO?
Kfin Technologies handles the allotment, refunds and credit of shares.
For information only. Not investment advice or a research report.
Full disclaimerSee how an IPO fits your plan
Armor checks every holding against your goals, risk and timeline.
Get the app